Login / Signup

Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.

Anne Marie Rosendahl MadsenFrederik Schaltz-BuchholzerThomas BenfieldMorten Bjerregaard-AndersenLars Skov DalgaardChristine DamSisse Bolm DitlevGulia FaiziIsik Somuncu JohansenPoul-Erik KofoedGitte Schultz KristensenEllen Christine Leth LoekkegaardChristian Backer MogensenLibin MohamedAnne OstenfeldEmilie Sundhaugen OedegaardMarcus Kjaer SoerensenChristian WejseAksel Karl Georg JensenSebastian NielsenTyra Grove KrauseMihai G NeteaPeter AabyChristine Stabell Benn
Published in: Trials (2020)
The trial was registered with EudraCT on April 16, 2020, EudraCT number: 2020-001888-90, and with ClinicalTrials.gov on May 1, 2020, registration number NCT04373291.Full protocol: The full protocol is attached as an additional file, accessible from the Trialswebsite (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.
Keyphrases
  • randomized controlled trial
  • study protocol
  • clinical trial
  • phase ii
  • open label